Navigation Links
SIRO Clinpharm Strengthens its Clinical Trials Supplies Service Offering in India

MUMBAI, India, Oct. 15 /PRNewswire/ -- SIRO Clinpharm, a global Contract Research Organization (CRO) with its base in India, US, Europe and Israel, today announced expansion of its Clinical Trials Supplies facility in Mumbai, India. This expansion has been fueled by a demand by pharmaceutical and biotech companies for storage and distribution of clinical trial supplies. The facility is strategically located in Mumbai.

"We opened our clinical trials supplies warehouse in 2003 with a modest area of 1800 square feet," said Jayanti Vaidyanath, Vice President, Administration, Legal & Clinical Trials Supplies Management. "Those days we were one of the few CROs based out of India to have such a facility. Now, with the expanded facility, we have a bigger area of 6200 square feet with room for further expansion. We currently have two walk-in cold rooms at 2-8 degree storage, ambient storage at 15-25 degrees and storages for temperature ranges between -20 and -70 degrees. We have also significantly strengthened our inventory management process using the recently implemented Oracle Siebel CTMS tool," she added.

"The facility expansion will enable us to handle many more orders thus increasing our ability to serve a wider client base," said Dr. Ajit Nair, President, India Operations. "Very recently, we have partnered with a global leader in logistics to support them in Clinical Trials Supplies management in India. This broadens our scope by making us a part of their global storage and distribution network and increases the platform to work on for our international pharma and biotech clients," he added.

About SIRO: SIRO Clinpharm Private Limited (SIRO) is among one of the leading global Clinical Research Organizations (CROs), offering full scope services, conducting clinical trials in the Pharmaceutical, Biotechnology and Medical Devices sectors in compliance with International Standards. SIRO is one of the first CROs founded in India, which caters to the needs of pharmaceutical companies across the world. The company has offices in India, USA, Israel and in Europe in Germany, Romania, Estonia, Czech Republic and Greece. For more information, please visit our website -


Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SIRO ClinPharm and Advanced Clinical Trial Solutions Ink Strategic Alliance
2. Medpace Strengthens Presence in Central Europe
3. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
4. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
5. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
6. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
7. Anavex strengthens Board of Directors
8. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
9. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
10. Strengthens Local Market Candidate Reach Through Acquisition
11. Strengthens Local Market Candidate Reach Through Acquisition
Post Your Comments:
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
(Date:11/24/2015)... 24, 2015 Cepheid (NASDAQ: CPHD ) ... the following conference, and invited investors to participate via ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ... New York, NY      Tuesday, December 1, ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
(Date:11/24/2015)... , November 24, 2015 SHPG ) announced ... in the Piper Jaffray 27 th Annual Healthcare Conference in ... 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ... Financial Officer, will participate in the Piper Jaffray 27 th ... NY on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 ...
Breaking Biology Technology:
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
Breaking Biology News(10 mins):